Medications for Diabetes Mellitus Noninsulindependent

36 results
  • atorvaliq - atorvaliq suspension

    (Atorvaliq)
    Cmp Pharma, Inc.
    Atorvaliq reduces cardiovascular risk (MI, stroke, angina) in adults with CHD risk factors, established CHD, or type 2 diabetes. Also lowers LDL-C in adults and children 10+ with primary hyperlipidemia, familial hypercholesterolemia, dysbetalipoproteinemia, or hypertriglyceridemia.
  • basaglar kwikpen - insulin glargine injection, solution

    (Insulin Glargine)
    Eli Lilly And Company
    Basaglar is a long-acting insulin indicated to improve glycemic control in adults and children with type 1 diabetes and in adults with type 2 diabetes. Not recommended for diabetic ketoacidosis.
  • brenzavvy - bexagliflozin tablet

    (Bexagliflozin)
    Theracosbio, Llc
    Brenzavvy is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is not recommended for type 1 diabetes.
  • caduet - amlodipine besylate and atorvastatin calcium tablet, film coated

    (Amlodipine Besylate And Atorvastatin Calcium)
    Pfizer Laboratories Div Pfizer Inc
    Caduet combines amlodipine and atorvastatin. Amlodipine treats hypertension, chronic stable angina, vasospastic angina, and reduces cardiovascular risk in documented CAD. Atorvastatin reduces cardiovascular events in high-risk adults and lowers LDL-C in hyperlipidemia, familial hypercholesterolemia, dysbetalipoproteinemia, and hypertriglyceridemia.
  • cycloset - bromocriptine mesylate tablet

    (Bromocriptine Mesylate)
    Avvisto Therapeutics Llc
    Cycloset is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Not for use in type 1 diabetes or diabetic ketoacidosis.
  • farxiga - dapagliflozin tablet, film coated

    (Dapagliflozin)
    Astrazeneca Pharmaceuticals Lp
    Farxiga is indicated for adults with chronic kidney disease, heart failure, or type 2 diabetes mellitus. It reduces risks of kidney disease progression, cardiovascular death, and heart failure hospitalization, and improves glycemic control in adults and children aged 10+ with type 2 diabetes as an adjunct to diet and exercise.
  • glyxambi - empagliflozin and linagliptin tablet, film coated

    (Empagliflozin And Linagliptin)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    GLYXAMBI (empagliflozin/linagliptin) is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Empagliflozin also reduces the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
  • humalog mix75/25 - insulin lispro injection, suspension

    (Insulin Lispro)
    Eli Lilly And Company
    Humalog Mix75/25 improves glycemic control in adults with diabetes mellitus. It is a fixed-ratio insulin blend (rapid- and intermediate-acting) and does not allow separate adjustment of basal and prandial doses.
  • inpefa - sotagliflozin tablet

    (Sotagliflozin)
    Lexicon Pharmaceuticals, Inc.
    INPEFA reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure, or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.
  • invokamet - canagliflozin and metformin hydrochloride tablet, film coated

    (Canagliflozin And Metformin Hydrochloride)
    Janssen Pharmaceuticals, Inc.
    Invokamet (canagliflozin/metformin) improves glycemic control in adults and children 10+ with type 2 diabetes as an adjunct to diet and exercise. Also reduces risk of major cardiovascular events and kidney disease progression in adults with type 2 diabetes and established CVD or diabetic nephropathy.